Large Pharmaceutical Company: Broad Customer and Economic Analyses
For a large pharmaceutical company, Oliver Wyman conducted broad customer and economic analyses to support a drug launch strategy. This included an analysis of patient clinical pathways, an analysis of physician reactions to complex selling media, as well as in-depth primary research of physician clinical patterns.
